Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06310200 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sphenopalatine Ganglion Block and Cold Induced Headaches

StatusActive, Not Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 31, 2025 (before its estimated May 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Notable Primary completion date: Nov 1, 2024 to May 1, 2025v3 Show 4 more changesShow less
    • Start date changed from estimate of Aug 1, 2024 to Jan 1, 2025
    • Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Study sites: 0 to 1
    • Study completion date: Dec 1, 2024 to Jul 1, 2025
  2. Notable Start date: Apr 1, 2024 to Aug 1, 2024
    • Primary completion date: Jun 1, 2024 to Nov 1, 2024
    • Study completion date: Jul 1, 2024 to Dec 1, 2024
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of this study is to determine if a sphenopalatine ganglion (SPG) block, performed through intranasal atomization of 4% lidocaine, is able to prevent cold induced cephalgia ("Brain Freeze"). Secondary objectives will be to determine the degree of decreased pain/duration of brain freeze after sphenopalatine ganglion block
Trial Details
NCT Number NCT06310200
Lead Sponsor Wright State University
Conditions
(from sponsor)
Cold Induced Headache, Brain Freeze, Cold Induced Cephalgia, Headache
Related terms Headache
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov